Format

Send to

Choose Destination
See comment in PubMed Commons below
Leukemia. 2012 Mar;26(3):424-32. doi: 10.1038/leu.2011.237. Epub 2011 Sep 9.

Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.

Author information

1
Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Thorkr@sund.ku.dk

Abstract

Cutaneous T-cell lymphoma (CTCL) is the term for diseases characterized by primary accumulation of malignant T cells in the skin. Patients with the two predominant clinical forms of CTCL called mycosis fungoides (MF) and Sézary syndrome (SS) characteristically develop severe immunodeficiency during disease progression and consequently patients with advanced disease frequently die of infections and not from the tumor burden. For decades, it has been suspected that the malignant T cells actively drive the evolving immunodeficiency to avoid antitumor immunity, yet, the underlying mechanisms remain unclear. The identification of a subset of highly immunosuppressive regulatory T cells (Tregs) triggered a variety of studies investigating if MF and SS are malignant proliferations of Tregs but seemingly discordant findings have been reported. Here, we review the literature to clarify the role of Tregs in MF and SS and discuss the potential mechanisms driving the immunodeficiency.

PMID:
21904385
DOI:
10.1038/leu.2011.237
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center